Habituelle Abortneigung: rationale Diagnostik und Therapie
Recurrent miscarriage (RM) affects 1-3% of couples during childbearing years worldwide and influences the life balance of patients and partners. So far, possible risk factors could be detected in up to 50% of RM patients including anatomical malformations, infectious diseases, endocrine dysfunctions...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | German |
| Published: |
2012
|
| In: |
Der Gynäkologe
Year: 2012, Volume: 45, Issue: 4, Pages: 309-321 |
| ISSN: | 1433-0393 |
| DOI: | 10.1007/s00129-011-2932-2 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s00129-011-2932-2 Verlag, Volltext: https://link.springer.com/article/10.1007/s00129-011-2932-2 
|
| Author Notes: | P. Beuter-Winkler, A. Germeyer, L.M. Wallwiener, B. Toth |
| Summary: | Recurrent miscarriage (RM) affects 1-3% of couples during childbearing years worldwide and influences the life balance of patients and partners. So far, possible risk factors could be detected in up to 50% of RM patients including anatomical malformations, infectious diseases, endocrine dysfunctions, genetic anomalies, acquired and inherited thrombophilia as well as (auto) immune disorders. Treatment strategies and options consist of surgical interventions, preimplantation genetic diagnosis, hormonal treatment and anticoagulant as well as immunomodulatory medication. This review will focus on established and new diagnostic and therapeutic options and discuss current literature. |
|---|---|
| Item Description: | First Online: 04 April 2012 Gesehen am 13.06.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1433-0393 |
| DOI: | 10.1007/s00129-011-2932-2 |